🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ping‐Hsien Lee

AstraZeneca (United States)

ORCID: 0000-0001-6491-2410
Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies”.

Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies

Cytotherapy(2021)10.1016/j.jcyt.2021.03.001
N/A
0.416DataRank · unranked
15 citations

Amy B Hont, Ashley Geiger, Samuel O'Brien, Robert Ulrey, Melanie Grant +9 more

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Blood(2020)10.1182/blood.2020008488
N/A
0DataRank · unranked
139 citations

Katherine M. Harris, Mariah Jensen-Wachspress, Vaishnavi V. Kankate, Haili Lang, Christopher A. Lazarski +28 more

Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation

Frontiers in Cellular and Infection Microbiology(2020)10.3389/fcimb.2020.00298
N/A
0DataRank · unranked
10 citations

Michael D. Keller, Patrick J. Hanley, Catherine M. Bollard, Ping‐Hsien Lee